[1] Heaton R K, Clifford D B, Franklin D R Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study[J]. Neurology, 2010,75(23):2087-2096.[2] Wu D T, Woodman S E, Weiss J M, et al. Mechanisms of leukocyte trafficking into the CNS[J]. J Neurovirol,2000,6 Suppl 1:S82-85.[3] Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection[J]. Retrovirology,2010,7:30.[4] Wang H, Sun J, Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide[J]. J Virol, 2008,82(15):7591-7600.[5] Meucci O, Miller R J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1[J]. J Neurosci,1996,16(13):4080-4088.[6] 丁渭,张玉林,乔录新,等.氧化损伤在HIV相关神经认知损害中的作用[J].首都医科大学学报,2012,33(5):602-609.[7] Cicala C, Arthos J. Virion attachment and entry: HIV gp120 env biotinylation, gp120 Env, or integrin ligand-binding assay[J]. Methods Mol Biol,2014,1087:3-12.[8] Tuzer F, Madani N, Kamanna K, et al. HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism[J]. Proteins,2013,81(2):271-290.[9] Roberts A J, Maung R, Sejbuk N E, et al. Alteration of methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120[J]. J Neurosci Methods,2010,186(2):222-225.[10] 张红梅,孙玉,柳雅立,等.gp120转基因小鼠制备及初步鉴定[J].首都医科大学学报,2010,31(6):695-700.[11] 盖祥云,赵瑛,刘琳,等.脑缺血后神经细胞凋亡致血管性痴呆的研究进展[J].中国脑血管病杂志,2010,7(11):614-616.[12] Sarkar R, Mitra D, Chakrabarti S. HIV-1 Gp120 protein downregulates nef induced IL-6 release in immature dentritic cells through interplay of DC-SIGN[J]. PLoS One, 2013,8(3):e59073.[13] 焦艳梅, 吴昊. HIV-1潜伏库研究进展[J]. 首都医科大学学报,2009,30(5):639-642.[14] Kanmogne G D, Schall K, Leibhart J, et al. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis[J]. J Cereb Blood Flow Metab,2007,27(1):123-134.[15] Tintori C, Selvaraj M, Badia R, et al. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120[J]. Chem Med Chem,2013,8(3):475-483.[16] Li W, Galey D, Mattson M P, et al. Molecular and cellular mechanisms of neuronal cell death in HIV dementia[J]. Neurotox Res,2005,8(1-2):119-134.[17] Mattson M P, Haughey N J, Nath A. Cell death in HIV dementia[J]. Cell Death Differ,2005,12 Suppl 1:893-904.[18] Shah A, Kumar S, Simon S D, et al. HIV gp120-and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1[J]. Cell Death Dis,2013,4:e850.[19] Haughey N J, Mattson M P. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120[J]. J Acquir Immune Defic Syndr,2002,31 Suppl 2:S55-61.[20] Scharf L, West A P Jr, Gao H, et al. Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody[J]. Proc Natl Acad Sci U S A,2013,110(15):6049-6054.[21] Adams J M, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy[J]. Oncogene,2007,26(9):1324-1337.[22] Ow Y P, Green D R, Hao Z, et al. Cytochrome c: functions beyond respiration[J]. Nat Rev Mol Cell Biol,2008,9(7):532-542. |